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Abstract
Objective The objective of this study was to compare the
periodontopathogen prevalence and tetracycline resistance genes
in Dominican patients with different periodontal conditions.
Methods Seventy-seven samples were collected from healthy,
gingivitis, chronic (CP) and aggressive (AgP) periodontitis pa-
tients. Porphyromonas gingivalis, Treponema denticola,
Tannerella forsythia, Aggregatibacter actinomycetemcomitans,
Fusobacterium nucleatum, Prevotella intermedia, Parvimonas
micra, Eikenella corrodens and Dialister pneumosintes and 11
resistance genes were studied by PCR. P. gingivalis fimA ge-
notype was determined.
Results In healthy patients, P. micra and P. intermedia were
the most and least frequently detected, respectively.
T. forsythia and E. corrodens appeared in 100 % of gingivitis
patients. Red complex, D. pneumosintes and E. corrodens
were significantly more prevalent in CP compared to healthy
patients. F. nucleatum and T. denticola were detected more
frequently in AgP. A. actinomycetemcomitans was the most
rarely observed in all groups. The fimA II genotype was the
most prevalent in periodontitis patients. Seven tetracycline-
resistant genes were detected. tet(Q), tet(32) and tet(W)
showed the greatest prevalence. tet(32) was significantly more
prevalent in CP than in healthy patients.
Conclusions Red complex bacteria andD. pneumosinteswere
significantly the most prevalent species among periodontitis
patients. T. forsythia was the most frequently detected in this
population. To our knowledge, this is the first study describing
the tet(32) gene in subgingival biofilm from healthy and peri-
odontally diseased subjects.
Clinical relevance This study contributes to the knowledge
on the subgingival microbiota and its resistance genes of a
scarcely studied world region. Knowing the prevalence of
resistance genes could impact on their clinical prescription
and could raise awareness to the appropriate use of antibiotics.
Keywords Periodontopathogens . Antimicrobial resistance
genes . Dominican Republic
Introduction
Periodontal disease is the result of an imbalance in the micro-
bial ecology of the oral cavity, and it also depends on host
susceptibility [1]. The prevalence of this disease is very high
in most populations, and gingivitis may affect up to 100 % of
the population [2]. Factors such as socio-economic back-
ground, gender, smoking, lifestyle or stress appear to have
an impact on the prevalence and severity of periodontitis in
any given population [3].
Clinical-microbiological studies have shown a close associ-
ation between periodontitis and the presence of a specific group
of microorganisms, mainly Porphyromonas gingivalis,
Aggregatibacter actinomycetemcomitans, Treponema denticola
and Tannerella forsythia [1, 2]. The prevalence of these
Electronic supplementary material The online version of this article
(doi:10.1007/s00784-015-1516-2) contains supplementary material,
which is available to authorized users.
* Vanessa Blanc
blanc@dentaid.es
1 Department of Periodontics, School of Dentistry, Pontificia
Universidad Católica Madre y Maestra (PUCMM), Santo
Domingo, Dominican Republic
2 Department of Microbiology, Dentaid Research Center, Dentaid S.
L., Ronda Can Fatjò 10, Parc Tecnològic del Vallès,
08290 Barcelona, Spain
3 Department of Periodontology, Graduate School, Universidad
Católica Santo Domingo, Santo Domingo, Dominican Republic
Clin Oral Invest (2016) 20:349–356
DOI 10.1007/s00784-015-1516-2
periodontal pathogens has been established in developed coun-
tries, and only in recent years has prevalence data of this type
been determined in some developing countries [2]. Compari-
sons of the periodontitis-associatedmicrobiota in different world
regions suggest that the distribution of periodontopathogens de-
pends upon geographic location and patient ethnic group [2, 4].
For example, significant differences have been reported for the
prevalence of A. actinomycetemcomitans in different European
populations [5]. Subjects of different ethnic origins living in the
USA have also shown different prevalences of this microorgan-
ism [6]. This species has also been described to show a high
frequency in populations of China and North Africa [7, 8] and a
low prevalence in Japan [9], USA [10] and Chile [11]. More-
over, inter- and intra-population clonal variability for different
virulence factors has been observed in this microorganism, [2,
12, 13].
Differences in prevalence have also been described for
P. gingivalis in different ethnic groups [2]. And similarly for
this species, genetic variability has been reported in genes
related with the synthesis of some virulence factors, for exam-
ple, the locus responsible for the synthesis of the capsule [14]
and the gene responsible for the synthesis of the fimbria
(fimA). Six genotypes have been described for the fimA gene,
and genotypes II and IV have been associated with periodon-
titis [2, 15, 16].
Moreover, an increase in multi-resistant strains in recent
years has led to considerable concern throughout the different
medical disciplines and has augmented the need to learn about
the mechanisms and genes involved in the said process [17,
18]. Relatively little information exists relating to resistance
patterns or to the resistance genes that could be present in
subgingival microbiota. Recent studies have reported periodon-
tal pathogens resistant to different antibiotics, with percentages
that vary according to the populations studied; this could be due
to the lack of control over antibiotic use and to poor patient
treatment compliance in certain countries [5, 19, 20]. Tetracy-
cline and some of its derivatives have been widely used as
adjuvants in the treatment of periodontitis, both topically and
systemically [21, 22]. Studies conducted in Europe and the
USA report a large presence of resistance genes to this antibi-
otic in microorganisms from the oral cavity, some of whose
frequencies differ, depending on the population studied.
Currently, there is only one study in the Dominican Repub-
lic on periodontal microbiota, involving 24 patients [23].
Using culture techniques, a predominance of enteric bacteria
and low prevalence and diversity of periodontopathogens
were described. Furthermore, in the Dominican Republic,
there have been no studies describing the presence of antibi-
otic resistance genes in subgingival microbiota. In view of the
above, the purpose of this study was to describe (i) the prev-
alence of periodontopathogens, (ii) the fimA gene type present
in P. gingivalis-positive samples and (iii) the frequency of
tetracycline resistance genes in subgingival samples of healthy
Dominican patients and those affected by gingivitis, chronic
periodontitis (CP) and aggressive periodontitis (AgP).
Material and methods
Subject population
Patients were selected from the Graduate School of Dentistry
at the Catholic University of Santo Domingo, Dominican Re-
public, between 2011 and 2012. Their clinical conditions were
def ined according to the American Academy of
Periodontology’s Periodontal Disease Classification Consen-
sus Report [24]. A total of 77 subjects were recruited
(Table 1). All subjects signed an institutional review board
(IRB)-approved informed consent form. The protocol and
study design were previously approved by the university’s
IRB. Patients with a diagnosis of gingivitis, CP and AgP were
considered candidates with each individual having at least 12
teeth, not counting third molars. Exclusion criteria included
cancer, cardiovascular disease, HIV infection, diabetes, arthri-
tis, pulmonary disease or any other systemic disease. Pregnant
women, subjects who had taken antibiotics and/or anti-
inflammatory drugs within 6 months prior to the study, heavy
smokers (>10 cigarettes per day) and patients with a previous
periodontal treatment were also excluded.
Clinical procedures
A complete periodontal examination, excluding third molars,
was performed on all subjects. The following clinical param-
eters were recorded: plaque index (PI), percentage of sites
with bleeding on probing (BOP), probing depth (PD) in
millimetres and clinical attachment level (CAL) in
millimetres. Six sites were examined for each tooth: mesio-
buccal, buccal, disto-buccal, disto-lingual, lingual and mesio-
lingual using a North Carolina periodontal probe. Periodontal
patients were described as having a minimum of four sites
with a pocket depth ≥4 mm and radiographic evidence of
alveolar bone loss.
Subgingival bacterial sampling and processing
Subgingival samples from CP and AgP were taken from the
four deepest periodontally affected sites with a probing depth
of ≥4 mm, one in each quadrant [25]. Sampled sites in healthy
and gingivitis patients had a probing depth of ≤3 mm, with the
deepest sites in each quadrant being selected. After isolating
the area with cotton rolls, supragingival deposits were careful-
ly removed with curettes and subgingival microbial samples
were obtained by inserting sterile paper points to the bottom of
the periodontal pocket and keeping them in place for 20 s.
Paper points were pooled in a sterile vial, and samples were
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sent to the microbiology laboratory (Dentaid Research Center,
Barcelona, Spain) at a controlled temperature of −20 °C for
processing. Genomic DNA was isolated from subgingival
samples using a QIAamp kit (Qiagen, Hilden, Germany) fol-
lowing the manufacturer’s instructions. Samples were previ-
ously treated with lysozyme (20 mg/mL) for 7 min at 37 °C.
The DNA concentration was quantified using a Nanodrop®
ND-1000 UV–Vis spectrophotometer (Nanodrop Technolo-
gies, Wilmington, DE, USA).
Bacterial detection by PCR and fimA gene type
identification
16S rDNA from P. gingivalis, T. denticola, T. forsythia,
A. actinomycetemcomitans, P. intermedia and Eikenella
corrodens was amplified using specific primers described by
Ashimoto et al. [10]. Specific primers for Parvimonas micra
(Pm1: 5′-CATgCAAgTCgAACgTgATT-3′ and Pm2: 5′-
CgAAAACCTTCTTCgCTCAC-3′) and Fusobacterium
nucleatum (Fn1: 5′-TAAAgCgCgTCTAggTggTT-3′ and Fn2:
5′-ACggCTTTgCAACTCTCTgT-3′) were designed using the
NCBI Reference Sequences NR_114338.1 and NR_074412.1,
respectively. Possible specific regions for primer design were
found through multiple alignments with other oral bacterial
sequences (ClustalW2 programme, http://www.ebi.ac.uk).
Primers were designed using the primer-Blast programme
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/). Specificity
was tested by PCR, using total DNA extracted from 15
collection strains as template, where only P. micra DSM
20468 and F. nucleatum DSM 20482 DNA tested positive.
The limit of detection was 102 cfu/ml which was determined
using the dilution of pure cultures from both strains.
Dialister pneumosintes primers and PCR conditions were
described by Doan et al. [26]. PCR mixes were performed in
25 μL containing 100 ng of template, 1x PCR buffer, 2.5 mM
of MgCl2, 0.2 mM of each dNTP, 1 μM of each primer and
0.5 U Taq Expand DNA polymerase.
The PCR amplification programme was standardised and
included initial DNA denaturation at 95 °C for 5 min and a
total of 35 PCR cycles and each cycle consisting of 1 min of
denaturation at 95 °C, 1 min of annealing at 55 °C and 1 min
of extension at 72 °C. Finally, an extension step was applied at
72 °C for 10 min. Sterilised Milli-Q water was used as tem-
plate for negative control in each reaction set, and pure DNA
from the following strains was used as positive control reac-
tions: P. gingivalis ATCC 33277, A. actinomycetemcomitans
DSM 8324, F. nucleatum DSM 20482, P. intermedia NCTC
13070, T. forsythia ATCC 43037, P. micra DSM 20468,
T. denticola ATCC 35405, E. corrodens NCTC 10596 and
D. pneumosintes ATCC 33048. PCR reactions were done in
duplicate. Amplification results were evaluated by electropho-
resis using 4 % agarose gel with ethidium bromide (0.5 g/mL)
in 1x TAE buffer. The 100 bp DNA Ladder (New England
Biolabs, Inc. Ipswich, MA, USA) served as the molecular
weight marker. The gels were photographed using a UV light
transilluminator GEL DOC™ XR+ system (Bio-Rad Labora-
tories Inc. Hercules, CA, USA).
fimA gene type (I, Ib, II, III, IV and V) identification was
carried out using specific primers and PCR conditions de-
scribed by Amano et al. [16] and Nakagawa et al. [27]. The
negative control was sterile Milli-Q water.
Detection of tetracycline resistance gene
The tetracycline resistance genes were detected performing mul-
tiplex PCR with 26 primers (Table 2). PCR mixes were per-
formed in 25 μL containing 100 ng of template, 1x PCR buffer,
1.0 mM of each dNTP, 0.5 μM of each primer and 1.0 U Taq
Expand DNA polymerase. The MgCl2 was 2.0 mM for mixes 1
and 2, and 2.5 mM for mixes 3 and 4. The amplification
programmes were as follows: 30 PCR cycles of (i) mix 1: 45 s
of denaturation at 95 °C, 45 s of annealing at 64 °C and 70 s of
extension at 72 °C; (ii) mix 2: 45 s of denaturation at 95 °C, 45 s
of annealing at 60 °C and 90 s of extension at 72 °C; (iii) mix 3:
30 s of denaturation at 95 °C, 30 s of annealing at 58 °C and 60 s
of extension at 72 °C; and (iv) mix 4: 30 s of denaturation at
95 °C, 30 s of annealing at 56.5 °C and 45 s of extension at 72 °C.
Negative and positive controls were used for each PCR
reaction. All reagents used for PCR reactions were purchased
from Roche Diagnostics (Penzberg, Germany). Amplification
reactions were carried out in a Thermal cycler T3000
(Biometra, Goettingen, Germany).









Age (range) 28.3 ± 7.9 (24–52) 36.30 ± 11.50 (20–56) 45.7 ± 10.1 (27–65) 33.9 ± 7.7 (18–46)
Females (N) 9 8 17 19
Sites with plaque (%) 2.2 ± 0.9 30 ± 4 54 ± 19 39 ± 17
Probing depth (mm) 1.5 ± 0.3 2.5 ± 0.5 4.4 ± 1.3 5.9 ± 2.2
Probing depth at samples site (mm) 2.1 ± 0.4 2.9 ± 0.2 5.6 ± 1.1 8.2 ± 1.5
CAL (mm) 0.4 ± 0.2 2.5 ± 0.4 5.1 ± 1.5 6.5 ± 2.1
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Statistical analysis
The statistical analysis was performed using SAS System®
v9.2 (SAS Institute Inc., Cary, NC, USA). For statistical tests,
a nominal significance level of 5 % (P < 0.05) was applied.
Standard methods were used to calculate descriptive statistics.
The association between bacterial detection and clinical pa-
rameters was tested using the Mann-Whitney for continuous
variables and chi-square or Fisher’s exact tests for categorical
factors. In order to compare the prevalence of each species, a
logistic regression method was performed for each diagnostic
group. Multiple comparisons with Tukey adjustment were al-
so performed. To assess whether a population’s prevalence of
some bacteria was different from the observed value of 100%,
the binomial test and Clopper-Pearson confidence limits were
calculated. Similarly, the chi-square test and a logistic regres-
sion method were performed to assess differences in preva-
lence of tet genes between the four diagnostic groups.
Results
Table 1 describes the clinical and demographic characteristics
of the study subjects. No statistically significant differences in
gender existed between groups. However, significant differ-
ences were observed between healthy and periodontitis pa-
tients in relation to probing depth (p < 0.001) and CAL
(p < 0.001) and to the percentage of sites with plaque
(p < 0.0001). Patients with AgP showed greater PD
(p < 0.0048) and CAL (p < 0.04) than patients with CP.
Averages of the total bacteria detected for each patient
group were as follows: healthy, 2.8 ± 1.6; gingivitis,
5.9 ± 1.3; CP, 6.9 ± 1.8; and AgP, 6.7 ± 1.7. In addition, the
use of the Mann-Whitney-Wilcoxon U test determined that
the bacterial average in the healthy subjects was significantly
lower than in the other groups, gingivitis (p = 0.0189), CP
(p = 0.0005) and AgP (p = 0.0011). Red complex bacteria
and F. nucleatum, P. micra and E. corrodens were detected
in more than 70 % of the patients studied (in all diagnostic
groups). However, the distribution of these species was not the
same throughout the four groups (Pearson’s chi-square,
p < 0.05) (Table 3).
In healthy subjects, the most frequent bacterium was
P. micra (63.6 %), although it is worth mentioning that
T. forsythiawas found in over 50 % of the healthy population.
Furthermore, P. intermedia was not found in this group.
P. gingivalis, T. denticola and T. forsythia were the most
prevalent in periodontally diseased patients. P. gingivalis and
T. denticola were significantly more prevalent in diseased pa-
tients compared to healthy patients. The detection frequency
of T. denticola in the healthy patient group was significantly
lower than in the CP and AgP patient groups, with p values of
0.0045 and 0.0048, respectively. And the same is observed
when studying the percentages of D. pneumosintes, as this
species was found mainly in patients with aggressive
Table 2 List of primers for
detection of different resistance
genes. It also indicates the
multiplex group and expected
amplicon sizes
Multiplex group Primer Sequence (5′-3′) Product size (bp) Source
1 TetM F
TetM R
GCG TAC AAG CAC AGA CTC GT




GAG AGC CTG CTATAT GCC AGC




AGA ATC TGC TGT TTG CCA GTG




GAA CCA GAT GCT GCT CTT




TCG TTA GCG TGC TGT CAT TC




GAA AGC TTA CTATAC AGTAGC




AAC TTA GGC ATT CTG GCT CAC




CAATCA CGC CCA AAA GAA




AATAGC CAC TAA ATG GGG CG




TCG ATA GGA ACA GCA GTA




ATG GTT CGC TAT TAC TCTAAC
ATC AGT CTC ATATTT CGA CA
177 This study
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(84.6 %) and chronic periodontitis (66.7 %). T. forsythia was
frequently detected in all groups studied, although it was sig-
nificantlymore prevalent in patients with chronic periodontitis
than in healthy patients. Moreover, the Clopper-Pearson test
showed statistical differences between the gingivitis group
and the healthy groups for this species. E. corrodens behaved
similarly to T. forsythia (Table 3).
F. nucleatum, T. forsythia and T. denticola had over 92 %
occurrence in AgP and were the most prevalent species in this
group. Of these three species, F. nucleatum and T. denticola
were much more frequently detected in these patients than in
healthy subjects. However, A. actinomycetemcomitans was
the least prevalent species in all patient groups, and no signif-
icant differences were observed for this species between the
healthy and diseased subjects. This bacterium was only pres-
ent in 24.7 % of the entire test population (Table 3).
Of the total patients included in the study, 77.9 % (n = 60)
tested positive for P. gingivalis. In 57 of these, the fimA gene
variant was determined. The III, Vand Ib genotypes were not
detected in any of the patients. By using Pearson’s chi-squared
test, it was determined that fimA I, II and IV genotypes were
not equally distributed across the four groups (p = 0.0003).
The genotype II frequency was significantly higher in AgP
(84 %) and CP (75.8 %) patients.
The presence of 11 tetracycline resistance genes was
analysed. tet(S), tet(31), tet(37) and tet(K) genes were not detect-
ed. tet(L) and tet(B) were only detected in one CP patient. This
set of six genes was excluded from subsequent statistical analy-
sis. The weighted average number of genes per patient showed
that in healthy subjects the value (1.47) was one point lower than
that obtained in patients with chronic periodontitis (2.88)
(Table 4). Lastly, we observed that the most frequently detected
gene in this population was tet(Q), which was present in 54 of
the 75 patients tested. And when comparing resistance gene
prevalence in the different patient groups, significant differences
were found for the tet(Q) and tet(32) genes. We observed that
these genes were muchmore prevalent in CP than in the healthy
patient group (p = 0.023 and p = 0.019, respectively).
Discussion
In this cross-sectional study, we used PCR to determine the
prevalence of nine periodontopathogens in the subgingival
microbiota of 77 Dominican patients diagnosed as healthy,
Table 3 Number and percentage of positive subjects for each microorganism in the four studied groups
Bacteria Healthy (n = 11) Gingivitis (n = 10) CP (n = 30) AgP (n = 26) Total (n = 77)
Na %b Na %b Na %b Na %b Na %b
P. gingivalis 2 18.2 7 70 28 93.3* 23 88.5* 60 77.9
T. denticola 3 27.3 9 90 27 90* 24 92.3* 63 81.8
T. forsythia 6 54.5 10 100 29 96.7* 24 92.3 69 89.6
A. actinomycetemcomitans 2 18.2 1 10 10 33.3 6 23.1 19 24.7
P. intermedia 0 0 2 20 16 53.3 7 26.9 25 32.5
F. nucleatum 5 45.4 9 90 24 80 24 92.3* 62 80.5
P. micra 7 63.6 8 80 27 90 23 88.5 65 84.4
D. pneumosintes 1 9.1 3 30 20 66.7* 22 84.6* 46 59.7
E. corrodens 5 45.4 10 100 27 90* 21 80.8 63 81.8
Mean bacteria in each group of patients (±SD) 2.8 ± 1.6 5.9 ± 1.3 6.9 ± 1.8 6.7 ± 1.7
aN number of positive subjects for each bacterium
b% percentage of positive subjects for each bacterium
*P values <0.05 obtained from statistical comparison between the prevalence data of healthy and diseased subjects
Table 4 Prevalence of antibiotic resistance genes in subgingival
samples from the different periodontal conditions
Gene Healthy Gingivitis CP AgP
P/A % P/A % P/A % P/A %
tet(31) 0/11 – 0/9 – 0/29 – 0/26 –
tet(32) 1/11 9.09 6/9 66.7 21/29 72.4 16/26 61.5
tet(37) 0/11 – 0/9 – 0/29 – 0/26 –
tet(B) 0/11 – 0/9 – 1/17 5.88 0/26 –
tet(K) 0/11 – 0/9 – 0/29 – 0/26 –
tet(L) 0/11 – 0/9 – 1/29 3.45 0/26 –
tet(M) 5/11 45.5 1/9 11.1 9/29 31.0 7/26 26.9
tet(O) 1/9 11.1 2/6 33.3 9/29 31.0 2/23 8.70
tet(Q) 5/11 45.5 6/9 66.7 24/29 82.8 19/26 73.1
tet(S) 0/11 – 0/9 – 0/29 – 0/26 –
tet(W) 4/11 36.4 2/9 22.2 18/29 62.1 17/26 65.4
WAN genes/patient 1/48 2.0 2.89 2.36
Due to a lack of samples, not all the patients could not be analysed
WAN weighted average number of genes per patient, P/A positive/all
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gingivitis, CP and AgP. The fimA genotypes were determined
in P. gingivalis-positive patients. Finally, the frequency of 11
tetracycline resistance genes was also analysed.
Little information is available regarding subgingival micro-
biota in Central America and the Caribbean countries. In the
Dominican Republic, only one work exists, in which by using
culturing methods, the subgingival microbiota of 24 patients
with advanced periodontitis were studied. In the said study, a
high rate of enteric bacteria was found and the onlymember of
the red complex detected was P. gingivalis. A low prevalence
of spirochetes was also observed [23]. Our study, using PCR,
showed an incidence of red complex microorganisms of
around 90 % in periodontitis patients. The high prevalence
of P. gingivalis in the CP group was similar to that obtained
in other studies performed in Colombia [33], Chile [11] and
Spain [34]. Although in our case, no significant differences
were found between the CP and AgP patient groups.
In subjects with CP, T. forsythia was the most frequently
detected species (96.7 %), which differs from that which is
described in other Latin American countries (Chile [16.2 %]
and Colombia [39 %]) [34] and in European countries, includ-
ing the Netherlands (73.3 %) [5], UK (44.4 %) [35] and Spain
(36.1 %) [34]. A high incidence of T. forsythia was also ob-
served in the healthy (54.5 %) and gingivitis (100 %) groups.
In Thai urban adults, Torrungruang et al. [36] observed a high
prevalence of T. forsythia in healthy and CP patients, and they
were not able to associate this microorganism with this dis-
ease. Further studies may be necessary to establish clear asso-
ciations between T. forsythia and periodontitis in the Domin-
ican population. It is likely that the use of PCR in our study
allowed us to observe this species more frequently compared
to other studies that only employed culture techniques [37,
38].
D. pneumosintes is a species that is frequently found in
deep sites and in severe forms of the disease [26, 39], a fact
that coincides with our study, as it was detectedmore frequent-
ly in patients with periodontitis compared to healthy or gingi-
vitis patients. Even so, the high colonisation of this species in
the Dominican Republic contrasts with that described by
Botero et al. in Colombia [33] and is similar to that found in
Brazil [39]. That being said, some studies report a frequency
for this species of greater than 70 % in healthy patients [40].
The literature indicates that there are differences between
the subgingival microbiota of the CP and AgP groups [24],
and further emphasises the strong association between the
presence of A. actinomycetemcomitans and AgP [41, 42]. In
our study, no significant differences were observed between
the species studied in the CP and AgP groups. Even
A. actinomycetemcomitans was less frequently detected in
AgP than in CP. The frequency of this species in the Domin-
ican Republic was similar to that reported in Chile (19.4 %)
[11] and higher than that described in Colombia (8.3 %) [33].
High prevalence of this bacterium has been reported for AgP
in other populations: 60.4 % in Morocco [8], 62 % in China
[7], 75 % in Korea [43], 80 % in Brazil [44] and 84.3 % in
Taiwan [45]. This may be due to ethnic differences between
populations [2, 3].
Some studies conducted in Brazil have found a high fre-
quency of the JP2 clone of A. actinomycetemcomitans [46,
47]; this overproducer of leukotoxin has been closely associ-
ated in some populations with AgP [48]. In our study, we
attempted to determine the presence of this clone, although
the sample amount only allowed for testing four
A. actinomycetemcomitans-positive samples (data not shown).
Nevertheless, we were able to observe the genetic variability
of the fimA gene of P. gingivalis. Fifty-seven of the 60
P. gingivalis-positive samples were studied, and fimA type II
was the most frequently found allele in periodontitis patients
(75.9 % [CP]; 84 % [AgP]). This is in agreement with other
studies where genotypes II and IVare more frequently detect-
ed in periodontitis patients than in healthy ones [2, 16, 49].
The oral cavity has been described as a reservoir of poten-
tially transferable antibiotic resistance genes [50]. In the Do-
minican Republic, there are no policies controlling the sale of
antibiotics, and the livestock industry is authorised to use sub-
therapeutic levels of antibiotic as growth promoters in poultry
feed [51]. This can result in the emergence of resistant or
multi-resistant bacterial strains [52]. Tetracyclines have been
used as a therapy for periodontitis as a monotherapy or as an
adjunct to scaling and root planing with different degrees of
efficacy [22]. Although nowadays it is not used regularly,
some of its derivatives are used in subantimicrobial doses
for the downregulation of metalloproteinase activity [53].
Studies have been carried out in Europe and the USA to ana-
lyse the subgingival presence of these resistance genes in
healthy and periodontally diseased subjects [50]. In our study,
we have tested for genes encoding efflux pumps: tet(31), tet(-
K), tet(L), ribosomal protection proteins (RPP): tet(B), tet(M),
tet(O), tet(Q), tet(S), tet(W) and tet(32) and enzymatic inacti-
vation tet(37). This covers the different resistancemechanisms
described for this antibiotic. Several of these genes have been
detected in bacteria from the oral cavity, while for other genes
no references exist in the literature in relation to the oral envi-
ronment [50, 54]. In our study, the most prevalent gene in
periodontitis was tet(Q) while tet(M) showed a low preva-
lence. However, studies by Ioannidis et al. [55] and Kim
et al. [56] reported both genes as the most frequent in diseased
patients in Europe and the USA, respectively. In Dominican
patients, tet(32) was the second most frequently detected gene
in periodontitis; it is worth noting that, to our knowledge, this
is the first study to report the presence of this gene in the
subgingival biofilm of healthy and periodontally diseased
patients.
The results of this study show a high prevalence of red
complex organisms in patients with CP and AgP. However,
the high incidence of T. forsythia in healthy and gingivitis
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patients may suggest further study is needed to determine the
role of this species in the Dominican population.
Unfortunately, a larger number of patients was not possible
for this study. Even so, and considering the existing knowl-
edge on subgingival microbiota and the presence and distri-
bution of antibiotic resistance genes in the Dominican Repub-
lic and Central America, we believe that this study provides
interesting data in relation to the subgingival microbiota of
this population, as some differences were found compared to
other studies performed in populations in America and
Europe.
Moreover, we found a wide variety of tetracycline resis-
tance genes with prevalences differing from those described in
European and North American populations. Considering the
current public health concern surrounding the presence of
multi-resistant bacteria caused by the use and abuse of antibi-
otics [18], it would be wise to conduct broader studies,
allowing us to map the diversity, distribution and dissemina-
tion of resistance genes in different countries in America.
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